- Research works
- 2 fractional, all time
- Citations
- 7 4.3 per fractional work
- Top-10% rate
- 64.1% record average 16.5%
- Open access
- 58% world 28%
Not ranked overall: Phase 3D (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Phase 3D (United States) publish most on?
By volume in 2022–2025: Pancreatic function and diabetes, Diabetes Management and Research, Diabetes and associated disorders and COVID-19 and healthcare impacts.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pancreatic function and diabetes Surgery 0 works
- 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
- 3 Diabetes and associated disorders Genetics 0 works
- 4 COVID-19 and healthcare impacts Oncology 0 works
- 5 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 6 Advances in Oncology and Radiotherapy Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Chicago
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Exelon (United States)
- Northern Trust (United States)
- University of Chicago Medicine Comprehensive Cancer Center
- Chan Zuckerberg Biohub Chicago
- BAND foundation
- Molson Coors Brewing Company (United States)
- I AM ALS
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.